Evidence map›Paper›PMID 37146262›Full record

ArticleBlood advances2023

Computer vision quantitation of erythrocyte shape abnormalities provides diagnostic, prognostic, and mechanistic insight.

Brody H Foy, Jonathan A Stefely, Pavan K Bendapudi, Robert P Hasserjian, Hanny Al-Samkari, Abner Louissaint, Megan J Fitzpatrick, Bailey Hutchison, Christopher Mow, Julia Collins and 8 more

Open access · goldAbstract read
In one paragraph

Article in Blood advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors at 2 institutions in 1 country.

Brody H FoyDepartment of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
Jonathan A StefelyDepartment of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA.ORCID 0000-0003-3235-1107
Pavan K BendapudiBlood Transfusion Service, Massachusetts General Hospital, Harvard Medical School, Boston, MA.ORCID 0000-0002-0754-7688
Robert P HasserjianDepartment of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA.ORCID 0000-0002-7753-0697
Hanny Al-SamkariDivision of Hematology, Massachusetts General Hospital, Harvard Medical School, Boston, MA.ORCID 0000-0001-6175-1383
Abner LouissaintDepartment of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
Megan J FitzpatrickDepartment of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
Bailey HutchisonDepartment of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA.ORCID 0000-0003-2236-8132
Christopher MowDepartment of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
Julia CollinsDepartment of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA.ORCID 0000-0003-4268-6007
Hasmukh R PatelDepartment of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
Chhaya H PatelDepartment of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
Nikita PatelDepartment of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
Samantha N HoDepartment of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
Richard M KaufmanDepartment of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Walter H DzikDepartment of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
John M HigginsDepartment of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA.ORCID 0000-0002-9182-0076
Robert S MakarDepartment of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
Harvard University · USBrigham and Women's Hospital · US

Funding

Antiangiogenic Therapy to Reduce Bleeding and Improve Health-Related Quality of Life in Hereditary Hemorrhagic TelangiectasiaK23HL159313 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI Hanny T Al-Samkari · 2022 to 2026
$999k
NHLBI NIH HHS K23 HL159313
6 · The paper itself

Abstract

Examination of red blood cell (RBC) morphology in peripheral blood smears can help diagnose hematologic diseases, even in resource-limited settings, but this analysis remains subjective and semiquantitative with low throughput. Prior attempts to develop automated tools have been hampered by their poor reproducibility and limited clinical validation. Here, we present a novel, open-source machine-learning approach (denoted as RBC-diff) to quantify abnormal RBCs in peripheral smear images and generate an RBC morphology differential. RBC-diff cell counts showed high accuracy for single-cell classification (mean AUC, 0.93) and quantitation across smears (mean R2, 0.76 compared with experts, interexperts R2, 0.75). RBC-diff counts were concordant with the clinical morphology grading for 300 000+ images and recovered the expected pathophysiologic signals in diverse clinical cohorts. Criteria using RBC-diff counts distinguished thrombotic thrombocytopenic purpura and hemolytic uremic syndrome from other thrombotic microangiopathies, providing greater specificity than clinical morphology grading (72% vs 41%; P < .001) while maintaining high sensitivity (94% to 100%). Elevated RBC-diff schistocyte counts were associated with increased 6-month all-cause mortality in a cohort of 58 950 inpatients (9.5% mortality for schist. >1%, vs 4.7% for schist; <0.5%; P < .001) after controlling for comorbidities, demographics, clinical morphology grading, and blood count indices. RBC-diff also enabled the estimation of single-cell volume-morphology distributions, providing insight into the influence of morphology on routine blood count measures. Our codebase and expert-annotated images are included here to spur further advancement. These results illustrate that computer vision can enable rapid and accurate quantitation of RBC morphology, which may provide value in both clinical and research contexts.

Indexed as

Erythrocytes, AbnormalHematologic DiseasesImage Processing, Computer-AssistedCell ShapeHumansMachine LearningPrognosisReproducibility of Results

Identifiers

PMID37146262
PMCPMC10448422
OpenAlexW4372333208

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.